Viewing Study NCT04793568


Ignite Creation Date: 2025-12-24 @ 5:42 PM
Ignite Modification Date: 2026-02-23 @ 4:54 AM
Study NCT ID: NCT04793568
Status: UNKNOWN
Last Update Posted: 2022-02-16
First Post: 2021-02-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Human Recombinant Interferon Gamma-1b for the Prevention of Hospital-acquired Pneumonia in Critically Ill Patients: a Double-blind, International, Phase 2, Randomized, Placebo-controlled Trial - the PREV-HAP Study
Sponsor: Nantes University Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module